T. Rowe Price Associates
SNCE

T. Rowe Price Associates’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

T. Rowe Price Associates’s Portfolio SNCE Stock Details SNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-509
Closed -$3K – 2976
2023
Q1 		$3K Hold
509
– – ﹤0.01% 2914
2022
Q4 		$4K Buy
+509
New +$9.96K ﹤0.01% 2918

Other funds holding SNCE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GCM
Glynn Capital Management Menlo Park, California $209M AUM 31.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

T. Rowe Price Associates's SNCE Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q2 2023, closing a stake of 509 shares — an estimated $3K sold.

T. Rowe Price Associates first reported a position in SNCE in Q4 2022 and held it in 2 quarters. The position peaked at $4K in Q4 2022. 51 funds tracked by Wall St. Rank hold SNCE as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 509 Science 37 Holdings, Inc. Common Stock shares in Q2 2023, an estimated $3K.
  • T. Rowe Price Associates first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • T. Rowe Price Associates's Science 37 Holdings, Inc. Common Stock position peaked at $4K in Q4 2022.
  • 51 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.